A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG. [electronic resource]
Producer: 20101012Description: 45-58 p. digitalISSN:- 1651-2006
- Aged
- Cardioplegic Solutions -- therapeutic use
- Cardiopulmonary Bypass
- Cardiotonic Agents -- therapeutic use
- Coronary Artery Bypass -- adverse effects
- Energy Metabolism
- Female
- Glucose -- therapeutic use
- Glutamic Acid -- administration & dosage
- Heart Failure -- etiology
- Humans
- Insulin -- therapeutic use
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Myocardial Contraction
- Myocardial Ischemia -- complications
- Myocardium -- metabolism
- Oxygen Consumption
- Potassium -- therapeutic use
- Recovery of Function
- Risk Assessment
- Risk Factors
- Severity of Illness Index
- Stroke Volume
- Sweden
- Time Factors
- Treatment Outcome
- Ventricular Dysfunction, Left -- complications
- Ventricular Function, Left
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.